Acquiring Company
Passage Bio
Acquired Company
Remix Therapeutics
United StatesWatertownBiotechnologyHealthcareHealth CareGeneticsTherapeuticsBiotechnologyDescription
Passage Bio, Inc. has approved the 2026 Equity Incentive Plan, contingent on the completion of the First Merger with Remix Therapeutics, Inc. This merger will enable Passage Bio to enhance its gene therapy capabilities and consolidate multiple incentive plans into one cohesive framework. The transition is designed to align incentive strategies for the combined entity.
Who to call at Passage Bio, and when
When Passage Bio changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Passage Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Passage Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Passage Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Passage Bio makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Remix Therapeutics?
Remix Therapeutics was acquired by Passage Bio, based in United States. The deal was reported on November 6, 2026. Passage Bio, Inc. (NASDAQ: PASG) is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Passage Bio is publicly traded (PASG) and operates in Biotechnology.
When did Passage Bio acquire Remix Therapeutics?
Passage Bio's acquisition of Remix Therapeutics was reported on November 6, 2026. Passage Bio, Inc. has approved the 2026 Equity Incentive Plan, contingent on the completion of the First Merger with Remix Therapeutics, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Remix Therapeutics do?
Remix Therapeutics is a biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways. It is privately held, operating in Biotechnology, and is based in Watertown.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.